Replies to post #179242 on Biotech Values

[bellweather1]

Re:TGTX's BOD Majority Control Issue

Yes, not to open old wounds, but Aria's board comes to mind.

The board and insiders there never came close to owning a majority of shares, yet they did manage to screw the shareholders on a fairly consistent basis.

So, I guess it boils down to a matter of integrity either way, which is why the issue is very possibly moot(lol)...

[DewDiligence]

TGTX—I know of PLENTY of biotech boards which are the exact opposite of what is being inferred of TGTX's BoD...and guess what? The Boards completely suck and aren't aligned with other investors at all.

Nobody thinks it’s good for shareholders to have a BoD with no skin in the game. However, there’s a happy medium between BoDs’ having no skin in the game and BoDs in which a single entity has control. Most biotech companies have BoDs in this in-between area.

p.s. Your use of the word inferred above is off-base. It’s a simple fact—not an inference—that a single entity controls 2/3 of TGTX’s BoD.